Home
Image
Meet Lloyd
U.S. Rep. Lloyd Doggett represents communities from Austin in the U.S. House of Representatives. He serves as Ranking Member of the Health Subcommittee on the House Ways & Means Committee, the oldest committee of the United States Congress. Doggett is also a member of the Ways and Means Select Revenue Measures Subcommittee, the Joint Committee on Taxation, and the House Budget Committee.
Latest News
Washington, D.C.—Today, U.S. Representative Lloyd Doggett (D-Austin) released the following statement:
“Yesterday, the FAA implemented another ground delay at Austin Bergstrom-International Airport (ABIA) on short notice, which affected numerous flights. Inbound flights on Sunday were delayed as much as two and a half hours. Travelers returning home and Central Texans meeting incoming passengers at the airport can expect more FAA-mandated delays during this busy holiday season. Best to check ahead as much as possible.
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-Texas) released the following statement regarding President Biden’s proposal for Medicare and Medicaid to cover costly weight-loss drugs:
“Big Pharma has been growing fat through price gouging—charging Americans the highest prices in the world. Instead of burdening Medicare with billions in additional costs, President Biden has the authority to reduce drug prices now for weight loss drugs and for drugs developed at taxpayer expense.
Issues:Healthcare
Washington, D.C.—Before Donald Trump assumes the White House and a Republican-led Congress attempts to obstruct progress on reigning in pharmaceutical companies, Representative Lloyd Doggett (D-Texas) and Senator Elizabeth Warren (D-Mass.) are urging the Biden Administration to fulfill its promise and finalize a strengthened framework to lower prescription drug prices and ensure increased transparency, oversight and accessibility of taxpayer-funded medical products. Specifically, the lawmakers ask Commerce Secretary Gina Raimondo and Health and Human Services Secretary Xavier Becerra to release the “Interagency Guidance Framework for Considering the Exercise of March-In Rights” by the end of the year.
Issues:Healthcare